Note de episod
Cancer research is moving fast, and emerging biomarkers can help inform and accelerate the pace of clinical trials, bringing new cancer treatments to patients more rapidly. Chief Scientific Officer Albert Koong, M.D., Ph.D., and Systems Biology Chair Nick Navin, Ph.D., discuss how new technologies and multimodal data integration are improving precision oncology for advanced cancer care.
Site: mdanderson.org

